Literature DB >> 26825768

Clinical Characteristics and Prognosis in Children and Adolescents With Autoimmune Hepatitis and Overlap Syndrome.

Adriana T Rodrigues1, Priscila M F Liu, Eleonora D T Fagundes, Thaís C N Queiroz, Pamela de Souza Haueisen Barbosa, Soraya L C Silva, Ana C Simões E Silva, Débora M Miranda, Alexandre R Ferreira, Luiz R Alberti.   

Abstract

OBJECTIVES: This is a cohort study of 134 children and adolescents with a known diagnosis of autoimmune hepatitis (AIH). During follow-up, some of them developed autoimmune sclerosing cholangitis (ASC). This study describes the characteristics of the patients upon diagnosis, and their response to treatment and any complications, and compares the patients who developed ASC during follow-up (ASC group) with those who did not (AIH group).
METHODS: A total of 73.1% of the patients were girls with a median age upon diagnosis of 10.41 (7.41-12.53) years.
RESULTS: Of 134 patients, 28 (20.9%) developed cholestatic manifestations, with features of ASC. A few differences were observed between the AIH and ASC groups when they were analyzed by χ test, such as the smaller predominance of girls in ASC group (P = 0.04), and more common asymptomatic presentation in the ASC group (P = 0.01). Cirrhosis was observed in 68% of biopsies, with no significant difference between groups (P = 0.43). Of 16 deaths, 15 were in the AIH group and 1 in the ASC group (P = 0.22). Of 11 transplants, 10 were in the AIH group and one in the ASC group (P = 0.53). The presence of cirrhosis at baseline was associated with a smaller survival probability (P = 0.015). The survival rate by Kaplan-Meier method was 94% at 5 years and 80% at 10 years, and was similar in both the groups (P = 0.08).
CONCLUSIONS: No statistically significant difference was observed between the groups in relation to prognosis and response to treatment.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26825768     DOI: 10.1097/MPG.0000000000001125

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  6 in total

1.  Biliary features in liver histology of children with autoimmune liver disease.

Authors:  Angelo Di Giorgio; A D'Adda; A Marseglia; A Sonzogni; L Licini; E Nicastro; L D'Antiga
Journal:  Hepatol Int       Date:  2019-05-08       Impact factor: 6.047

2.  Overlap Syndrome Involving Systemic Lupus Erythematosus and Autoimmune Hepatitis in Children: A Case Report and Literature Review.

Authors:  Wan-Tz Lai; Wan-Hua Cho; Hock-Liew Eng; Ming-Hui Kuo; Fu-Chen Huang
Journal:  Front Pediatr       Date:  2019-07-31       Impact factor: 3.418

3.  The efficacy and safety of different doses of glucocorticoid for autoimmune hepatitis: A systematic review and meta-analysis.

Authors:  Chi Zhang; Shan-Shan Wu; Xiao-Qin Dong; Zhao Wu; Hong Zhao; Gui-Qiang Wang
Journal:  Medicine (Baltimore)       Date:  2019-12       Impact factor: 1.817

4.  Autoimmune Sclerosing Cholangitis in Children: A Prospective Case-Control Study.

Authors:  Nagendra Kumar; Ujjal Poddar; Rajnikant Yadav; Hira Lal; Krushna Pani; Surender Kumar Yachha; Anshu Srivastava; Rakesh Pandey
Journal:  Pediatr Gastroenterol Hepatol Nutr       Date:  2021-03-08

Review 5.  Treatment of Overlap Syndromes in Autoimmune Liver Disease: A Systematic Review and Meta-Analysis.

Authors:  Benjamin L Freedman; Christopher J Danford; Vilas Patwardhan; Alan Bonder
Journal:  J Clin Med       Date:  2020-05-13       Impact factor: 4.241

6.  Primary Sclerosing Cholangitis and Autoimmune Hepatitis Overlapping Syndrome Complicated by Ulcerative Colitis.

Authors:  Takanori Suzuki; Itaru Naitoh; Takahito Katano; Kentaro Matsuura; Yoshihito Nagura; Kei Fujiwara; Shunsuke Nojiri; Hiromi Kataoka
Journal:  Intern Med       Date:  2022-02-01       Impact factor: 1.282

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.